<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>IMPROVEMENT OF IMMUNOHEMATOLOGICAL CHARACTERISTICS AND PROPHYLAXIS OF COMORBID HEMORRHAGIC VASCULITIS AND NEPHROPATHY IN CHILDREN</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Mamadaliyeva</mods:namePart><mods:namePart type="family">Hilolaxon</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>The comorbid course of hemorrhagic vasculitis (Henoch–Schönlein purpura) and nephropathy in children is associated with more severe clinical manifestations and profound immune-hematological disturbances. The study investigated immune and hematological parameters (IgA, IgG, IgM, CD4+/CD8+ ratio, complement C3, and blood indices). Results revealed elevated IgA levels, activation of the complement system, and a reduced CD4+/CD8+ ratio. The improved preventive program — including immunomodulatory therapy and long-term follow-up — reduced relapse frequency and preserved renal function in affected children.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-11-11</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>